Yantai Zhenghai Biotechnology Co., Ltd. (SHE:300653)
15.25
-0.15 (-0.97%)
Sep 2, 2026, 3:04 PM CST
SHE:300653 Revenue
Yantai Zhenghai Biotechnology had revenue of 78.74M CNY in the quarter ending June 30, 2026, a decrease of -12.92%. This brings the company's revenue in the last twelve months to 336.07M, down -4.81% year-over-year. In the year 2025, Yantai Zhenghai Biotechnology had annual revenue of 364.14M with 0.25% growth.
Revenue (ttm)
336.07M
Revenue Growth
-4.81%
P/S Ratio
8.14
Revenue / Employee
886.73K
Employees
379
Market Cap
2.74B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 364.14M | 913.16K | 0.25% |
| Dec 31, 2024 | 363.23M | -50.43M | -12.19% |
| Dec 31, 2023 | 413.65M | -19.57M | -4.52% |
| Jan 1, 2023 | 433.22M | 33.05M | 8.26% |
| Dec 31, 2021 | 400.18M | 106.89M | 36.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Universal Biotech | 1.15B |
| Shandong Sito Bio-technology | 1.12B |
| Zhejiang East Asia Pharmaceutical | 990.47M |
| Guangdong VTR Bio-Tech | 814.07M |
| Landfar Bio-medicine | 660.26M |
| Jilin Jian Yisheng Pharmaceutical | 650.83M |
| Hubei Goto Biopharm Group | 650.05M |
| Zhejiang Shouxiangu Pharmaceutical | 611.43M |